Bank of Montreal
QNCX icon

Bank of Montreal’s Quince Therapeutics QNCX Stock Holding History

Bank of Montreal’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$44K – 4658
2021
Q1 		$44K Sell
6
-7
-54% -$50.4K ﹤0.01% 3762
2020
Q4 		$77K Buy
13
+9
+225% +$79.7K ﹤0.01% 3723
2020
Q3 		$42K Sell
4
-3
-43% -$27.3K ﹤0.01% 3511
2020
Q2 		$63K Buy
7
+6
+600% +$55K ﹤0.01% 3316
2020
Q1 		$4K Sell
1
-7
-88% -$69.1K ﹤0.01% 3735
2019
Q4 		$93K Buy
+8
New +$48.3K ﹤0.01% 3536

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

Bank of Montreal's QNCX Position: Q2 2021 in Review

Bank of Montreal sold out of Quince Therapeutics (QNCX) in Q2 2021, closing a stake of 6 shares — an estimated $44K sold.

Bank of Montreal first reported a position in QNCX in Q4 2019 and held it in 6 quarters. The position peaked at $93K in Q4 2019. 100 funds tracked by Wall St. Rank hold QNCX as of Q2 2021.

  • Bank of Montreal reported no remaining Quince Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 6 Quince Therapeutics shares in Q2 2021, an estimated $44K.
  • Bank of Montreal first reported a position in Quince Therapeutics in Q4 2019 and held it in 6 quarters.
  • Bank of Montreal's Quince Therapeutics position peaked at $93K in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.